Susquehanna International Group, LLP Clene Inc. Call Options Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
Call Options
12 transactions
Others Institutions Holding CLNN
# of Institutions
6Shares Held
230KCall Options Held
0Put Options Held
25K-
Morgan Jess S & CO Inc112KShares$504,0000.27% of portfolio
-
Black Rock Inc. New York, NY83.5KShares$375,5290.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ25.2KShares$113,5350.0% of portfolio
-
Jefferies Group LLC New York, NY4.96KShares$22,3020.0% of portfolio
-
Cutler Group LP3.9KShares$17,5500.0% of portfolio
About Clene Inc.
- Ticker CLNN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,502,000
- Market Cap $286M
- Description
- Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...